Tim Bertram, Ph.D.

Tim Bertram, Ph.D.

Former Chief Executive OfficeratProkidney· In proxies 2022–2023

Pay in FY2023-84% from the year before · Prokidney stock -74.1% the same year

Tim Bertram, Ph.D. was paid $7.6M in FY2023 (Dec), down 84%. Prokidney stock fell 74.1% that year.

Pay$100 in the stock at the end of FY21 → $18
Pay is from the Summary Compensation Table of each Prokidney proxy. The stock line is the value of $100 put in the stock at the start, from the price change of each fiscal year. Dividends are not in it.

Experience

  1. ProkidneyPublic company · 4 yr
    • Former Chief Executive Officer2022 – Present · 4 yrStock in role -85%

Roles come from the proxy statements of each company.

Activity

Two people shown as one, or a wrong number?